Despite surpassing its average analyst price target, Micron’s forward valuation and memory bottleneck economics point toward ...

RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.

Fastenal posted Q4 EPS of $0.26, matching estimates, while revenue came in at $2.03B, slightly below forecasts. The company ...

ImmunityBio shares jumped in premarket trading after the FDA outlined next steps for expanding ANKTIVA’s bladder cancer label ...

M posted a Q4 earnings and revenue beat, delivering $1.83 adjusted EPS and $6.1 billion in sales, while forecasting growth in ...

D.R. Horton beat Wall Street estimates in Q1 fiscal 2026 as earnings rose to $2.03 per share and revenue came in at $6.9 ...

With risk assets retreating and commodities exploding higher, investors are hunting for durable growth stories trading below ...

QXO stock declined over 6% in premarket trading after announcing a 31.6 million share offering priced at $23.80, below its ...

ImmunityBio stock jumped after the company reported preliminary 2025 net product revenue of $113 million, up about 700% year ...

Wells Fargo topped Q4 profit expectations with $1.76 EPS, but revenue came in slightly below forecasts at $21.29 billion.

State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring ...

TSMC stock jumped nearly 6% in premarket trading after the company beat Q4 earnings estimates and raised its 2026 capex plan ...